INTRODUCTION AND OBJECTIVES:
To assess the significance of mannitol used as renal protective agent during nephronsparing surgery (NSS) on renal functional outcomes after NSS.
METHODS: A prospective, randomized, placebo-controlled, double-blind, phase 3 trial (ClinicalTrials.gov identifier NCT01606787) designed to detect a 5% difference between treatment arms with a power of 90%. Patients were randomized 1:1 to receive mannitol (12.5 g) or normal saline solution placebo intravenously within 30 min prior to renal vascular clamping. Eligibility criteria included age >18 yr, renal artery clamping during NSS, and preoperative estimated glomerular filtration rate (eGFR) >45 mL/min/1.73m 2 . Intraoperatively, a standardized fluid management algorithm was used to maintain hemodynamic stability and urine output 0.5 mL/kg/h. Postoperatively, eGFR was obtained at 6 wk and 6 mo. A renal scan was obtained pre operatively and at the 6-mo endpoint. An ANCOVA model was used to assess the differences in eGFR at 6 wk and 6 mo, and in renal scan at 6 mo after NSS. Differences in grade 3-5 complications were assessed using Fisher 0 s exact test. At the interim analysis on the first 88 patients, the O 0 Brien-Fleming stopping boundaries requiring a significance level of 0.0031 were not met (p ¼ 0.6).
RESULTS: A total of 105 patients per treatment arm were enrolled. After excluding 11 patients (7 in the placebo and 4 in the mannitol arm) who did not undergo NSS; 2 patients (1 in each arm) converted to radical nephrectomy, and 1 patient from the mannitol arm who never received the study drug, 98 and 101 patients in the placebo and mannitol arms, respectively, were evaluated. Median age was 56 yr (interquartile range [IQR] 48, 63) and 60 yr (IQR 50, 66) in the placebo and mannitol arm, respectively. Comparing placebo to the mannitol arm, the adjusted difference of 0.2 eGFR units at 6 mo after NSS was not significant (95% confidence interval [CI] -3.1, 3.5; p ¼ 0.9). The adjusted difference of -2.6 eGFR units at 6 wk after NSS was not significant (95% CI -5.8, 0.7; p ¼ 0.12). No significant differences were detected between treatment arms in median split function on 6-mo renal scan (difference -1.7; 95% CI -3.8, 0.4; p ¼ 0.11), or in grade 3-5 complication rates within 90 days of NSS (difference 3.2%; 95% CI -4.1%, 11%; p ¼ 0.4).
CONCLUSIONS: This randomized prospective trial provides evidence against the use of mannitol as renal protective agent during NSS since no clinical or statistically significant advantage to the use of intravenous mannitol in patients undergoing NSS was found.
Source of Funding: Institutional

MP49-02 PERIOPERATIVE MORBIDITY OF CLAMP VS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY)
INTRODUCTION AND OBJECTIVES: The impact of ischemic damage on kidney function residual to partial nephrectomy (PN) remains a controversial issue. The clamping of the artery is more frequent during minimally invasive PN compared with the open counterpart. The CLOCK study (CLamp vs Off Clamp the Kidney during partial nephrectomy, clinicaltrial.gov registration n NCT02287987) is a perspective, randomized, multicentre trial, started in September 2014, still recruiting, with the goal of 200 patients, to compare renal function preservation after robotic partial nephrectomy (RAPN). Local ethical committee approval was obtained by every center. Here an 00 ad interim 00 intention-to-treat analysis of the perioperative morbidity of the two procedures is reported.
METHODS: Up to September 2016, 137 patients were centrally randomized to be submitted to clamp vs off-clamp RAPN at 6 institutions. Inclusion criteria were normal coagulative function, healthy contralateral kidney, estimated GFR 60 ml/min, R.E.N.A.L score 10 and previous surgeon experience >50 RAPN and center surgical volume >100 renal tumors/year. Split renal function was evaluated preoperatively and after 6 months by DTPA renal scan. Data were collected in an e-crf, centrally managed.
RESULTS: No significant differences were observed for baseline features, duration of surgery, oncological outcomes and complications, whereas there was a difference in the severity of bleeding as perceived by the surgeon and in estimated blood loss (table no.1). A shift from an off-clamp to clamp technique was observed in 29/67 patients (43.3%), established preoperatively (3 cases, 10.3%), intraoperatively before starting the resection (10, 34.5%) or during the resection because of bleeding (16, 55.2%). A shift from clamp to offclamp procedure was observed in 10/70 cases (14.3%), always preoperatively.
CONCLUSIONS: Off-clamp and clamped RAPN are equally safe in terms of oncological outcomes and complications. However, even for tumors with a low/intermediate complexity, at high-volume centers and for skilled surgeons, despite the setting of a RCT, in a relevant rate of cases off-clamp PN is not feasible due to bleeding while only in a few cases clamping the artery is deemed as redundant.
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THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 INTRODUCTION AND OBJECTIVES: Robot-assisted partial nephrectomy (RAPN) is reportedly superior to laparoscopic partial nephrectomy (LPN) in renal function preservation. This is partly due to the shortened warm ischemia time (WIT), but related evidence remains unclear. This study aimed to examine the cause of renal functional loss after minimally invasive partial nephrectomy.
METHODS: A total of 273 patients underwent LPN (n ¼ 141) or RAPN (n ¼ 132) at a single institution between 2010 and 2015. The factors influencing the >10% decrease in the estimated glomerular filtration rate (eGFR) 6 months postoperatively were evaluated, and the percentage of decrease in eGFR and parenchymal volume were compared in LPN and RAPN matched cohorts.
RESULTS: The mean WIT was significantly longer (24 vs. 18 minutes, p < 0.001) and the postoperative decrease in eGFR 6 months after surgery was significantly higher (-9.9% and -3.4%, p < 0.001) in LPN than in RAPN. Multivariate analysis showed that the >10% postoperative decrease in eGFR was significantly influenced by the surgical procedure (p ¼ 0.0004), but not by WIT (p ¼ 0.07). Patient variables, including age, sex, body mass index, tumor size, RENAL nephrometry score (RENAL-NS), preoperative eGFR, and WIT, were adjusted, and each group included 42 patients (mean tumor size 23 mm, RENAL-NS 6.4, preoperative eGFR 69 mL/min/1.73 m2, WIT 21 minutes). Six months after surgery, the percentage of decrease in eGFR (-9.4% vs. -1.9%, p ¼ 0.0008) and parenchymal volume (-23% vs. -9%, p < 0.0001) was significantly higher in LPN than in RAPN.
CONCLUSIONS: The better preservation of renal function in RAPN, compared with LPN, is not caused by shortened WIT but by better preservation of parenchymal volume.
Source of Funding: none
MP49-04 EXCISED PARENCHYMAL MASS AND DEVASCULARIZED PARENCHYMAL MASS ASSOCIATED WITH PARTIAL NEPHRECTOMY: IMPACT ON FUNCTIONAL RECOVERY
Wen Dong*, Jitao Wu, Chalairat Suk-Ouichai, Elvis Carabello, Diego Aguilar Palacios, Erick Remer, Jianbo Li, Joseph Zabell, Sudhir Isharwal, Steven Campbell, Cleveland, OH INTRODUCTION AND OBJECTIVES: Loss of nephron mass is the predominant factor associated with functional outcomes after partial nephrectomy (PN), and can be due to excised parenchymal mass (EPM) and/or devascularized parenchymal mass (DPM). In this study, we are going to evaluate the importance of EPM and DPM relative to functional recovery after PN.
METHODS: A total of 168 patients managed with PN had necessary studies to determine EPM and DPM and evaluate parenchymal mass changes and functional loss within the operated kidney. Parenchymal mass loss in the ipsilateral kidney was measured from CT scans <2 months prior and 3-12 months after PN. EPM was estimated from pathologic specimen by subtracting tumor volume from specimen volume. Tumor volume was measured from preoperative CT, and specimen volume estimated from defatted specimen weight after adjusting for tissue density and proportionate changes related to lack of blood flow ex vivo. DPM was defined as total parenchymal mass loss minus EPM. Patients with a contralateral kidney were required to have nuclear renal scans within the same timeframes. Pearson correlation evaluated the relationship between GFR preservation and parenchymal mass loss, and multivariable analysis assessed predictors for DPM.
RESULTS: Median tumor size was 3.4 cm, median R.E.N.A.L score was 7, and 32 patients (19%) had a solitary kidney. Warm/cold ischemia were utilized in 100/68 patients, respectively. Median EPM and DPM were 9cm3 and 16cm3, respectively. Median GFR preserved was 89% globally and it was 79% in the operated kidney. While total parenchymal mass loss and DPM correlated strongly with GFR preservation in the operated kidney (both p<0.001), EPM failed to correlate with functional outcomes (r<0.2). Preoperative GFR and endophytic status associated with DPM on multivariable analysis.
CONCLUSIONS: Devascularization during reconstruction associates strongly with functional outcomes after PN, which has important implications regarding surgical technique. Prospective study will be required to further evaluate the relative values of EPM and DPM.
